 |
|
Methyldopa for Treatment of Hypertension
Sheldon G. Sheps, MD;
Alexander Schirger, MD;
Philip J. Osmundson, MD;
John F. Fairbairn II, MD
JAMA. 1963;184(8):616-621.
Abstract
Methyldopa is an enzyme inhibitor and an effective antihypertensive agent in man. In a study of 33 hypertensive patients, mean blood pressure levels were reduced more than 10% for the sitting position in 61%, and for the standing position in 71%. There were indications of liver damage in seven patients, probable drug fever in one, fluid retention in four, and aggravation of angina pectoris in two. The best indication for the use of methyldopa appeared to be renal insufficiency in hypertensive patients. The authors hesitate to advocate other than investigational use of this drug until the significance of its effects on the heart and liver are more clearly established.
Author Affiliations
Rochester, Minn.
From the Mayo Clinic and Mayo Foundation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Methyldopa-Induced Decrease in Mental Activity
Adler
JAMA 1974;230:1428-1429.
ABSTRACT
Orally Administered Methyldopa: Hemodynamic Effects in the Presence and Absence of Congestive Heart Failure
Kranz et al.
Arch Intern Med 1974;134:478-483.
ABSTRACT
Mild Hypertension and Antihypertensive Drugs
Robinson
JAMA 1973;225:1247-1248.
ABSTRACT
Methyldopa-Induced Submassive Hepatic Necrosis
Rehman et al.
JAMA 1973;224:1390-1392.
ABSTRACT
Co-operative Clinical Trial of Alpha-methyldopa: III. Double-blind Control Comparison of Alpha-methyldopa and Chlorothiazide, and Chlorothiazide and Rauwolfia
SMITH et al.
ANN INTERN MED 1966;65:657-671.
ABSTRACT
Effects of Methyldopa in Hypertension
Igloe
JAMA 1964;189:188-190.
ABSTRACT
|
